REC-3964
REC-3964-201
Phase 2 small_molecule terminated
Quick answer
REC-3964 for Recurrent Clostridioides Difficile Infection is a Phase 2 program (small_molecule) at RECURSION PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- RECURSION PHARMACEUTICALS, INC.
- Indication
- Recurrent Clostridioides Difficile Infection
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated